Look for Drugs and Conditions

Representative image

KPMG Report Highlights Economic and Health Toll of Tobacco in India

A recent report by KPMG Assurance and Consulting Services titled "Human-Centric Approach to Tobacco Control" has shed light on the substantial economic and health burdens imposed by tobacco use in India. According to the report, India loses a significant 1% of its GDP annually due to diseases and premature deaths attributed to tobacco consumption, ranking second globally in tobacco usage.


The report underscores the alarming prevalence of tobacco use among young adults aged 20-44, with approximately 49% of respondents in this demographic consuming tobacco in both smoking and oral forms, as per a 2023 survey.

Dr. Narender Saini, Former General Secretary of the Indian Medical Association, emphasized the dual impact of tobacco on health and the economy. Respiratory ailments, cardiovascular diseases, and various forms of cancer are prevalent among tobacco users, leading to premature deaths and financial strain on affected families.

India grapples with the challenge of both smoking and oral tobacco use, with legally produced cigarettes comprising only 8% of total consumption. Cheaper tobacco products such as bidis and chewing tobacco dominate the market, contributing to widespread usage.

Furthermore, the report highlights the growing issue of illicit cigarette trade in India, with the market valued at Rs 22,930 crore in 2022. The proliferation of illegal tobacco products poses a significant challenge to government revenue and public health efforts.

To address these challenges, the report advocates for a diverse array of alternative products and cessation techniques to support individuals in quitting tobacco. A holistic and collaborative approach involving producers, consumers, regulatory agencies, public health professionals, and support groups is deemed essential in combating tobacco consumption effectively.

Dr. Chhavi Gupta, Senior Consultant at Yashoda Super-Specialty Hospital, Ghaziabad, emphasizes the importance of leveraging technology to enhance outreach efforts and making nicotine replacement therapy (NRT) more affordable and accessible.

The inclusion of NRT products in the National Tobacco Control Program by the Ministry of Health and Family Welfare underscores the government's commitment to harm reduction. Additionally, several states have implemented bans on the manufacturing and sale of oral tobacco products, signaling progress in tobacco control efforts.

The report calls for a holistic roadmap towards tobacco harm reduction in India, emphasizing the need for proactive collaboration between stakeholders to develop innovative and effective strategies. By working together, India can strive towards a future where the burden of tobacco-related diseases is significantly reduced, and the well-being of its citizens is safeguarded.



0 Comments
Be first to post your comments

Post your comment

Related Articles

Ad 5